Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-1154P is a human pseudogene derived from the U6 small nuclear RNA gene family. U6 snRNA is a core component of the spliceosome, the molecular machinery responsible for pre-mRNA splicing in eukaryotic cells[3][1]. U6 snRNA genes are highly conserved and present in multiple copies across species, but many become pseudogenes that lose canonical function through mutations or truncations[3][6]. RNU6-1154P belongs to this class and is presumed non-functional, lacking protein-coding capacity and documented biological role. There is no evidence linking RNU6-1154P to any cellular function, disease, or drug interaction[5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 1154, pseudogene (RNU6-1154P).